Common Contracts
4 similar Warrant Agreement contracts by Corautus Genetics Inc, Genstar Therapeutics Corp
GENSTAR THERAPEUTICS CORPORATION COMMON STOCK PURCHASE WARRANT Void after December 19, 2002Warrant Agreement • March 28th, 2003 • Corautus Genetics Inc • Biological products, (no disgnostic substances) • California
GenStar Therapeutics Corporation, a Delaware corporation (the “Company”), hereby certifies that, for value received, CEOcast, Inc., or its permitted assigns, is entitled, subject to the terms set forth below, to purchase from the Company at any time or from time to time before 5:00 p.m. Pacific time, on December 19, 2002 (the “Expiration Time”), 50,000 fully paid and nonassessable shares of Common Stock of the Company at a purchase price per share equal to the Warrant Price (as defined herein) and otherwise in accordance with the terms hereof. The number and character of such shares of Common Stock and the Warrant Price therefor are subject to adjustment as provided below.
GENSTAR THERAPEUTICS CORPORATION COMMON STOCK PURCHASE WARRANT Void after May 8, 2005Warrant Agreement • March 28th, 2003 • Corautus Genetics Inc • Biological products, (no disgnostic substances) • California
transaction maintain beneficial ownership and voting control of a majority of the outstanding voting securities of the surviving entity in the same relative proportions as they did prior to such transaction.
GENSTAR THERAPEUTICS CORPORATION COMMON STOCK PURCHASE WARRANT Void after June 19, 2005Warrant Agreement • March 28th, 2003 • Corautus Genetics Inc • Biological products, (no disgnostic substances) • California
GenStar Therapeutics Corporation, a Delaware corporation (the “Company”), hereby certifies that, for value received, CEOcast, Inc., or its permitted assigns, is entitled, subject to the terms set forth below, to purchase from the Company at any time or from time to time before 5:00 p.m. Pacific time, on June 19, 2005 (the “Expiration Time”), 100,000 fully paid and nonassessable shares of Common Stock of the Company at a purchase price per share equal to the Warrant Price (as defined herein) and otherwise in accordance with the terms hereof. The number and character of such shares of Common Stock and the Warrant Price therefor are subject to adjustment as provided below.
GENSTAR THERAPEUTICS CORPORATION COMMON STOCK PURCHASE WARRANT Void after October 18, 2006Warrant Agreement • March 29th, 2002 • Genstar Therapeutics Corp • Electromedical & electrotherapeutic apparatus • California
GenStar Therapeutics Corporation, a Delaware corporation (the “Company”), hereby certifies that, for value received, SCO Financial Group LLC, or its permitted assigns, is entitled, subject to the terms set forth below, to purchase from the Company at any time or from time to time before 5:00 p.m. Pacific time, on October 18, 2006 (the “Expiration Time”), 89,500 fully paid and nonassessable shares of Common Stock of the Company at a purchase price per share equal to the Warrant Price (as defined herein) and otherwise in accordance with the terms hereof. The number and character of such shares of Common Stock and the Warrant Price therefor are subject to adjustment as provided below.
